Role of angiogenic factors in acute experimental Strongyloides venezuelensis infection

Parasite Immunology

Volumn 32, Issue 6, 2010, Pages 430-439

  Shariati, F ^a   Perez Arellano J L ^b   Lopez Aban J ^a   El Behairy, A M ^c   Muro, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Cairo University   (Egypt)

Author keywords

Endostatin; Fibroblast growth factor (FGF2); Nitric oxide; Strongyloides venezuelensis; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; NITRIC OXIDE; PARASITE ANTIGEN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS MACROPHAGE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRONGYLOIDES VENEZUELENSIS; STRONGYLOIDIASIS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ENDOSTATINS; FECES; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; PARASITE EGG COUNT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRONGYLOIDES; STRONGYLOIDIASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; STRONGYLOIDES VENEZUELENSIS;

EID: 77952253051     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01202.x     Document Type: Article

References (35)

1. Siddiqui AA Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001 33 : 1040 1047.
2. Vadlamudi RS, Chi DS Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 2006 4 : 8.
3. McHugh TD, Jenkins T, Greenwood R McLaren DJ. The migration and attrition of Strongyloides ratti in naive and sensitized rats. J Helminthol 1994 68 : 143 148.
4. Tsuji N, Ohta M Fujisaki K. Expression of a 70-kDa heat-shock-related protein during transformation from free-living infective larvae to the parasitic stage in Strongyloides venezuelensis. Parasitol Res 1997 83 : 99 102.
5. Csermely L, Jaafar H, Kristensen J, et al. Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. World J Gastroenterol 2006 12 : 6401 6404.
6. Thompson BF, Fry LC, Wells CD, et al. The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc 2004 59 : 906 910.
7. Carmeliet P Jain RK. Angiogenesis in cancer and other diseases. Nature 2000 407 : 249 257.
8. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001 26 : 25 35.
9. Ferrara N Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997 18 : 4 25.
10. Bikfalvi A, Klein S, Pintucci G Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997 18 : 26 45.
11. Bouïs D, Kusumanto Y, Meijer C, Mulder NH Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 2006 53 : 89 103.
12. Benezra R Rafii S. Endostatin's endpoints-deciphering the endostatin antiangiogenic pathway. Cancer Cell 2004 5 : 205 206.
13. Martins WA, Melo AL, Nicoli JR, et al. A method decontaminating Strongyloides venezuelensis larvae for the study of strongyloidiasis in germ-free and conventional mice. J Med Microbiol 2000 49 : 387 390.
14. Conway DJ, Lindo JF, Robinson RD, Bundy DA Bianco AE. Strongyloides stercoralis: characterization of immunodiagnostic larval antigens. Exp Parasitol 1994 79 : 99 105.
15. Northern C Grove DI. Strongyloides stercoralis: antigenic analysis of infective larvae and adult worms. Int J Parasitol 1990 20 : 381 387.
16. Machado ER, Ueta MT, Gonçalves-Pires MR, Alves de Oliveira JB, Faccioli LH Costa-Cruz JM. Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. Mem Inst Oswaldo Cruz 2003 98 : 849 851.
17. Brindley PJ, Gam AA, Pearce EJ, Poindexter RW Neva FA. Antigens from the surface and excretions/secretions of the filariform larva of Strongyloides stercoralis. Mol Biochem Parasitol 1988 28 : 171 180.
18. Yang ZF, Ho DW, Chu AC, Wang YQ Fan ST. Linking inflammation to acute rejection in small-for-size liver allografts: the potential role of early macrophage activation. Am J Transplant 2004 4 : 196 209.
19. Jyo-Oshiro Y, Sasaki T, Kawakami Y, et al. Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis. Virchows Arch 1999 435 : 501 508.
20. Andrade MA, Siles-Lucas M, Espinoza EY, Pérez-Arellano JL, Gottstein B Muro A. Echinococcus multilocularis laminated layer components and the E14t 14-3-3 recombinant protein decrease NO production by activated rat macrophages in vitro. Nitric Oxide Biol Chem 2004 10 : 150 155.
21. Espinoza E, Muro A, Martin MM, Casanueva P Pérez-Arellano JL. Toxocara canis antigens stimulate the production of nitric oxide and prostaglandin E2 by rat alveolar macrophages. Parasite Immunol 2002 24 : 311 319.
22. Taylor MJ, Cross HF, Ford L, Makunde WH Bilo K. Wolbachia bacteria in filarial immunity and disease. Parasite Immunol 2001 23 : 401 409.
23. Viney ME Lok JB. Strongyloides spp. WormBook 2007 23 : 1 15.
24. Baek BK, Whang IS, Islam MK, Kim BS Kakoma I. Persistent infection with Strongyloides venezuelensis in the Mongolian gerbil (Meriones unguiculatus). Korean J Parasitol 2002 4 : 181 186.
25. Ferreira V, Molina MC, Schwaeble W, Lemus D Ferriera A. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis? J Parasitol 2005 21 : 4.
26. Debrah AY, Mand S, Toliat MR, et al. Plasma vascular endothelial growth factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg 2007 77 : 4.
27. Jain V, Armah HB, Tongren JE, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malaria J 2008 7 : 83 98.
28. Abdollahi A, Hlatky L Huber PE. Endostatin: the logic of antiangiogenic therapy. Drug Resist 2005 8 : 59 74.
29. Puxeddu N, Berkman AH, Nissim Ben Efraim DE, et al. The role of eosinophil major basic protein in angiogenesis. Allergy 2008 64 : 368 374.
30. Tsai HC, Liu YC, Lee SS, Chen ER Yen CM. Vascular endothelial growth factor is associated with blood brain barrier dysfunction in eosinophilic meningitis caused by Angiostrongylus cantonensis infection. Am J Trop Med Hyg 2007 76 : 592 595.
31. Wang C, Duan H He L. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro. Eur J Pharmacol 2009 612 : 143 152.
32. Shariati F, Pérez-Arellano JL, López-Abán J, Arefi M, Martínez-Fernández AR Muro A. Trichinella: differential expression of angiogenic factors in macrophages stimulated with antigens from encapsulated and non-encapsulated species. Exp Parasitol 2009 123 : 347 353.
33. Chin K, Kurshima Y, Ogura T, Tajiri H, Yoshida S Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 1997 15 : 437 442.
34. He T, Ai M, Zhao XH Xing YQ. Inducible nitric oxide synthase mediates hypoxia-induced hypoxia-inducible factor-1 alpha activation and vascular endothelial growth factor expression in oxygen-induced retinopathy. Pathobiology 2007 74 : 336 343.
35. Singh RP Agarwal R. Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents. Curr Cancer Drug Targets 2007 7 : 475 483.